Total Pharmacy Services, Inc.

FDA inspection history in Houma, Louisiana, 2013 to 2014

2
Form 483s
1
Warning letter

Every document, by year

  • Form 483
  • Warning letter

2013: one Form 483; 2014: one Form 483 and one warning letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2013–14Two Form 483s and one warning letter, at Houma, Louisiana.
  2. 2013The longest 483 on file: 11 observations over 4 pages at Houma, Louisiana.

Cited most

Across all Total Pharmacy Services observations on file

The complete Total Pharmacy Services file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2014-09-30483 Form 483$99
2014-02-24Warning letter Warning letter$99
2013-05-22483 Form 483$99

Investigators on these documents

Claire M. Minden (1)

FEI number 3010116308 · most recent document Sep 30, 2014

About Total Pharmacy Services, Inc.

How many FDA Form 483s has Total Pharmacy Services, Inc. received?

FDA Intel has 2 Form 483s on file for Total Pharmacy Services, Inc.; the most recent is dated Sep 30, 2014.

When was Total Pharmacy Services, Inc. last inspected by FDA?

The most recent FDA inspection document on file for Total Pharmacy Services, Inc. is a Form 483 dated Sep 30, 2014, for the site in Houma, Louisiana.

What did FDA cite at Total Pharmacy Services, Inc.?

The regulations cited most in the observations on file for Total Pharmacy Services, Inc. are 21 CFR 211.113(b) (Control of microbiological contamination), 3 times; 21 CFR 211.42(c)(10)(iv) (Design and construction features), 3 times; 21 CFR 211.165 (Testing and release for distribution), 2 times.

Has Total Pharmacy Services, Inc. received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Total Pharmacy Services, Inc.; the most recent is dated Feb 24, 2014.

Total Pharmacy Services, Inc. FDA Inspection History & 483s · FDA Intel